欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

Inflammation/Immunology

货号 产品名 CAS号 信息
CSN22353 AZ3451 2100284-59-9 AZ3451 is a protease-activated receptor-2 (PAR2) antagonist.
CSN22493 Pumaprazole 158364-59-1 Pumaprazole is a reversible proton pump antagonist.
CSN22357 Beperidium iodide 86434-57-3 Beperidium iodide shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93.
CSN22336 ACP-105 899821-23-9 ACP-105 is a potent nonsteroidal selective androgen receptor modulator (SARM) with partial agonist activity relative to the natural androgen testosterone.
CSN22337 Adavivint 1467093-03-3 Adavivint is a potent and selective inhibitor of canonical Wnt signaling, with an EC50 of 19.5 nM via a high-throughput TCF/LEF-reporter assay in SW480 colon cancer cells.
CSN22483 Fezagepras sodium 1254472-97-3 PBI-4050 acts as an agonist for GPR40 and as an antagonist or inverse agonist for GPR84.
CSN22471 Sodium 9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylate 69049-74-7 Nedocromil Sodium is a potent TNF-α inhibitor with an IC50 value of 1.67 μM for Blood eosinophils.
CSN22442 KRN2 248260-75-5 KRN2 is a selective inhibitor of nuclear factor of activated T cells (NFAT5), with an IC50 of 0.1 μM.
CSN22508 SM 16 614749-78-9 SM 16 is an an ATP-competitive ALK5/ALK4 inhibitor with IC50 value between 160 and 620 nM for inhibition of TGF-β1-induced Smad2/3 phosphorylation in cell study.
CSN22157 Mapracorat 887375-26-0 Mapracorat is a novel selective glucocorticoid receptor agonist with IC 50 of 0.2 nM.
CSN21433 Methyl-3β-hydroxycholenate 20231-57-6 L 601920-0 is a ROR gamma modulator extracted from patent US20110263046 A1, in figure 2.
CSN22454 Lymecycline 992-21-2 Lymecycline is a tetracycline derivative, with broad-spectrum antibacterial activity and also has anti-inflammatory property.
CSN22143 ERB-196 550997-55-2 ERB-196 is a nonsteroidal selective estrogen receptor-β (ERβ) agonist.
CSN22119 AZD7624 1095004-78-6 AZD7624 is an inhaled p38 inhibitor, with potent anti-inflammatory activity.
CSN22191 MK-0429 227963-15-7 MK-0429 is a potent integrin antagonist with IC50s of 12.2 nM (α5β1 integrin) and 2.8 nM (αvβ3 integrin), respectively.
CSN22182 PF-4878691 532959-63-0 PF-4878691 is a potent and selective Toll-like receptor 7 (TLR7) agonist.
CSN22183 DW-1350 491577-61-8 DW-1350 is a LTB4 receptor antagonist.
CSN22201 CI-1044 197894-84-1 CI-1044 is an orally active PDE4 inhibitor with IC50s of 0.29, 0.08, 0.56, 0.09 μM for PDE4A5, PDE4B2, PDE4C2 and PDE4D3, respectively.
CSN22186 GW 766994 408303-43-5 GW 766994 is a specific and oral chemokine receptor-3 (CCR3) antagonist, which has entered clinical trial for asthma and eosinophilic bronchitis.
CSN22167 BMY-25271 78441-82-4 BMY-25271 is a histamine H2 receptor antagonist.
CSN22204 Bimosiamose 187269-40-5 Bimosiamose is a pan-selectin antagonist, inhibits E-, P-, and L-selectin with IC50s of 88 μM, 20 μM, and 86 μM, respectively, and can be used in the research of inflammatory disease.
CSN22225 NecroX-5 1383718-29-3 NecroX-5 is a derivative of the NecroX, reduces intracellular calcium concentration, and possesses anti-inflammatory and anti-cancer activity.
CSN22206 Parimifasor 1796641-10-5 Parimifasor is an immunomodulator, with anti-inflammatory activity.
CSN22249 Taprenepag isopropyl 1005549-94-9 Taprenepag isopropyl is a highly selective EP2 receptor agonist.
CSN22338 AE-3763 291778-77-3 AE-3763 is a peptide-based human neutrophil elastase inhibitor with an IC50 of 29 nM.
CSN22386 Dihydromunduletone 674786-20-0 Dihydromunduletone is a selective adhesion G protein–coupled receptor antagonist (aGPR) with an IC50 of ~21 μM.
CSN22375 Cl-amidine 913723-61-2 Cl-amidine is a peptidylarginine deminase (PAD) inhibitor, with an IC50 5.9±0.3 μM for PAD4.
CSN22388 (S)-(6-(2-Chlorophenyl)-1,4-dimethyl-7,10-dihydro-4H-pyrido[4',3':4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-9(8H)-yl)(cyclopropyl)methanone 131614-02-3 E-​6123 is a platelet-activating factor (PAF) receptor antagonist.
CSN22390 E6130 1427058-33-0 E6130 is an orally available and highly selective CX3CR1 modulator, that may be effective for treatment of inflammatory bowel disease.
CSN22333 A-69412 123606-23-5 A-69412 is a reversible, specific inhibitor of the hydrophilic 5-lipoxygenase (5-LO).
CSN22367 CDK8-IN-3 1884500-15-5 CDK8-IN-3 is an inhibitor of CDK8 extracted from patent WO2016041618A1, compound example 1.7.
CSN22434 JAK-IN-5 2096999-92-5 JAK inhibitor 1 is an inhibitor of JAK extracted from patent US20170121327A1, compound example 283.
CSN22347 AN-3485 1213827-99-6 AN-3485 is a benzoxaborole analog, Toll-Like Receptor(TLR) inhibitor with IC50 values ranging from 18 to 580 nM.
CSN22435 JAK-IN-1 1334673-53-8 JAK-IN-1 is a JAK1/2/3 inhibitor with IC50s of 0.26, 0.8 and 3.2 nM, respectively. JAK-IN-1 shows improved selectivity for JAK3 over JAK1.
CSN22372 Olacaftor 1897384-89-2 CFTR corrector is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator extracted from patent US9782408.
CSN22418 GNE-0946 1677667-24-1 GNE-0946 is a potent and selective RORγ( RORc) agonist with an EC50 value of 4 nM for HEK-293 cell.
CSN22433 Iralukast 151581-24-7 Iralukast is a cysteinyl-leukotriene antagonist (CysLT) with a pKi of 7.8 for CysLT1.
CSN22383 Dagrocorat 1044535-52-5 Dagrocorat is a novel and dissociated Glucocorticoid Receptor Agonist.
CSN22419 GNE-4997 1705602-02-3 GNE-4997 is a potent and selective ITK/TSK inhibitor.
CSN22420 GNE-6468 1677668-27-7 GNE-6468 is a potent and selective RORγ(RORc) agonists with an EC50 value of 13 nM for HEK-293 cell.
CSN22521 TNF-α-IN-1 444287-49-4 TNF-α-IN-1 is a TNF-α inhibitor extracted from patent US20030096841A1, compound example I-7.
CSN22409 Gefapixant 1015787-98-0 Gefapixant is an orally active P2X3 receptor (P2X3R) antagonist with IC50s of ~30 nM versus recombinant hP2X3 homotrimers and 100-250 nM at hP2X2/3 heterotrimeric receptors.
CSN22498 ROCK2-IN-2 1995065-79-6 ROCK2-IN-2 is a selective ROCK2 inhibitor extracted from patent US20180093978A1, Compound A-30, has an IC50 of <1 μM.
CSN22421 GPR84 antagonist 8 1445846-30-9 GPR84 antagonist 8 is a selective GPR84 antagonist.
CSN22523 Trehalose 6-behenate 66755-19-9 Trehalose 6-behenate is a Th1/Th17 skewing vaccine adjuvant.
CSN22422 GSK 4027 2079896-25-4 GSK 4027 is a chemical probe for the PCAF/GCN5 bromodomain with an pIC50 of 7.4±0.11 for PCAF in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.
CSN22535 YM-264 131888-54-5 YM-264 is a selective, potent and orally active platelet-activating factor (PAF) antagonist with a pKi value of 8.85 for rabbit platelet membranes.
CSN22482 PAT-505 1782070-22-7 PAT-505 is a potent, selective, noncompetitive and orally available autotaxin inhibitor, with an IC50 of 2 nM in Hep3B cells, 9.7 nM in human blood and 62 nM in mouse plasma.
CSN22495 RGX-104 HCl 610318-03-1 RGX-104 is a small-molecule LXR agonist that modulates innate immunity via transcriptional activation of the ApoE gene.
CSN24268 Mitoquinone mesylate 845959-50-4 Mitoquinone Mesylate is a ubiquinone derivative, TPP-based and mitochondrially targeted antioxidant, preventing lipid peroxidation-induced apoptosis and protecting mitochondria from oxidative damage.
<< PREV 1 2 3 4 5 6 7 8 9 NEXT >>
联系
我们